Literature DB >> 22138461

Preradiotherapy calcium scores of the coronary arteries in a cohort of women with early-stage breast cancer: a comparison with a cohort of healthy women.

Mirjam E Mast1, Mark W Heijenbrok, Anna L Petoukhova, Astrid N Scholten, Joop H M Schreur, Henk Struikmans.   

Abstract

PURPOSE: Breast cancer radiotherapy has been associated with an increased risk of cardiac toxicity. However, no data are available on the probability of developing coronary artery disease (CAD) in breast cancer patients when compared with healthy women. Therefore, baseline coronary artery calcium (CAC) scores, as an accepted tool to predict CAD, were determined and compared with the CAC scores of a healthy, asymptomatic cohort, the Multi-Ethnic Study of Atherosclerosis (MESA) cohort. METHODS AND MATERIALS: Eighty consecutive patients with ductal carcinoma in situ or infiltrative breast cancer referred for radiotherapy after breast-conserving surgery were included in our study. Their cardiovascular risk profile was registered, and a 64 multislice CT scan was performed. The CAC scores of an unselected (Caucasian only) Radiotherapy Centre West (RCWEST) cohort, as well as of those of a selected (comorbidity and race adjusted) RCWEST cohort, were determined. The scores of both cohorts were compared with those of the female (Caucasian only) MESA cohort.
RESULTS: For the unselected RCWEST cohort (n = 62) we found significant (p < .01) higher scores for women in the 55-64 age category compared with those of the MESA cohort. In the selected cohort (n = 55) the CAC scores of the women in the age category 55-64 were significantly (p = .02) higher compared with the MESA cohort. No significant differences were noted in the other age categories.
CONCLUSION: Both cohorts revealed that CAC scores in the 55-64 age category were significantly higher than the CAC scores in the asymptomatic (female) MESA population. These data suggest that breast cancer patients bear a higher risk of developing coronary heart disease before the start of radiotherapy. Therefore, measures to decrease cardiac dose further in breast cancer radiotherapy are even more important.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22138461     DOI: 10.1016/j.ijrobp.2011.08.012

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

Review 1.  Cardiovascular Risk in Breast Cancer Patients Receiving Estrogen or Progesterone Antagonists.

Authors:  Anne H Blaes; G J van Londen; Nicole Sandhu; Amir Lerman; Daniel A Duprez
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-04-30

Review 2.  Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.

Authors:  Anne Blaes; Anna Prizment; Ryan J Koene; Suma Konety
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

3.  Cardiovascular risk factors among cancer patients qualified for systemic treatment. Analysis of a cardiovascular disease-free cohort from the Polish multicentre study ONCOECHO.

Authors:  Marta Nowakowska; Edyta Płońska-Gościniak; Andrzej Szyszka; Łukasz Chrzanowski; Magdalena Krakowska; Piotr Potemski; Katarzyna Mizia-Stec; Zbigniew Gąsior; Artur Bodys; Maciej Siński; Adrianna Gościńska-Szmagała; Piotr Gościniak; Monika Różewicz; Beata Zaborska; Wojciech Braksator; Dariusz Kosior; Jarosław D Kasprzak
Journal:  Arch Med Sci       Date:  2020-11-02       Impact factor: 3.318

Review 4.  Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.

Authors:  Vinisha Garg; Gabriel Vorobiof
Journal:  Curr Oncol Rep       Date:  2016-08       Impact factor: 5.075

5.  Heart dose and coronary artery calcification in patients receiving thoracic irradiation for lung cancer.

Authors:  Anel Yakupovich; Mark A Davison; Michael Z Kharouta; Julius Turian; Christopher W Seder; Marta Batus; Louis F Fogg; Dinesh Kalra; Mark Kosinski; Tuncay Taskesen; Tochukwu M Okwuosa
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

6.  A comparative assessment of coronary artery calcification on chest CT scans of patients referred to a cardio-oncology clinic.

Authors:  Alison M Brann; Charlotte J Bai; John F Hibbeln; Kim A Williams; Tochi M Okwuosa
Journal:  Cardiooncology       Date:  2016-10-06

Review 7.  Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer.

Authors:  Juan C Lopez-Mattei; Eric H Yang; Maros Ferencik; Lauren A Baldassarre; Susan Dent; Matthew J Budoff
Journal:  JACC CardioOncol       Date:  2021-12-21

8.  Cardioprotective medication use in Black and white breast cancer survivors.

Authors:  Arnethea L Sutton; Ashley S Felix; Dipankar Bandyopadhyay; Reuben Retnam; William G Hundley; Vanessa B Sheppard
Journal:  Breast Cancer Res Treat       Date:  2021-04-02       Impact factor: 4.624

9.  Cancer and Its Association With the Development of Coronary Artery Calcification: An Assessment From the Multi-Ethnic Study of Atherosclerosis.

Authors:  Matthew C Whitlock; Joseph Yeboah; Gregory L Burke; Haiying Chen; Heidi D Klepin; W Gregory Hundley
Journal:  J Am Heart Assoc       Date:  2015-11-09       Impact factor: 5.501

10.  Reporting of coronary artery calcification on chest CT studies in breast cancer patients at high risk of cancer therapy related cardiac events.

Authors:  William J Phillips; Christopher Johnson; Angeline Law; Michele Turek; Alex R Small; Joao R Inacio; Susan Dent; Terrence Ruddy; Rob S Beanlands; Benjamin J W Chow; Gary R Small
Journal:  Int J Cardiol Heart Vasc       Date:  2018-02-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.